These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 28643452)

  • 21. Nanomedicine-Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy.
    Wang J; Zhang B; Sun J; Wang Y; Wang H
    Adv Ther (Weinh); 2020 Jan; 3(1):. PubMed ID: 34277929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer.
    Zhang R; Song X; Liang C; Yi X; Song G; Chao Y; Yang Y; Yang K; Feng L; Liu Z
    Biomaterials; 2017 Sep; 138():13-21. PubMed ID: 28550753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced nanomaterials for hypoxia tumor therapy: challenges and solutions.
    Sundaram A; Peng L; Chai L; Xie Z; Ponraj JS; Wang X; Wang G; Zhang B; Nie G; Xie N; Rajesh Kumar M; Zhang H
    Nanoscale; 2020 Nov; 12(42):21497-21518. PubMed ID: 33094770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The efficiency of the radiobiological and clinical of the intraoperative radiation therapy in combination with distant gamma-radiation therapy of malignant tumors].
    Radiats Biol Radioecol; 2005; 45(6):664-9. PubMed ID: 16454332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
    Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology enabled radioprotectants to reduce space radiation-induced reactive oxidative species.
    Babu B; Pawar S; Mittal A; Kolanthai E; Neal CJ; Coathup M; Seal S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1896. PubMed ID: 37190884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.
    Luo Z; Tian H; Liu L; Chen Z; Liang R; Chen Z; Wu Z; Ma A; Zheng M; Cai L
    Theranostics; 2018; 8(13):3584-3596. PubMed ID: 30026868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Applications of Nanoparticles in Improving the Outcome of Lung Cancer Treatment.
    Girigoswami A; Girigoswami K
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy.
    Huang J; Huang Q; Liu M; Chen Q; Ai K
    Front Pharmacol; 2022; 13():844037. PubMed ID: 35250594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
    Yasuda H
    Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-Intensity Focused Ultrasound- and Radiation Therapy-Induced Immuno-Modulation: Comparison and Potential Opportunities.
    Cirincione R; Di Maggio FM; Forte GI; Minafra L; Bravatà V; Castiglia L; Cavalieri V; Borasi G; Russo G; Lio D; Messa C; Gilardi MC; Cammarata FP
    Ultrasound Med Biol; 2017 Feb; 43(2):398-411. PubMed ID: 27780661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
    Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
    Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core-shell TaOx@MnO
    Gong F; Chen J; Han X; Zhao J; Wang M; Feng L; Li Y; Liu Z; Cheng L
    J Mater Chem B; 2018 Apr; 6(15):2250-2257. PubMed ID: 32254565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bi
    Zang Y; Gong L; Mei L; Gu Z; Wang Q
    ACS Appl Mater Interfaces; 2019 May; 11(21):18942-18952. PubMed ID: 31058495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convergence of nanotechnology with radiation therapy-insights and implications for clinical translation.
    Chatterjee DK; Wolfe T; Lee J; Brown AP; Singh PK; Bhattarai SR; Diagaradjane P; Krishnan S
    Transl Cancer Res; 2013 Aug; 2(4):256-268. PubMed ID: 25279336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in light ion radiation therapy.
    Brahme A
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):603-16. PubMed ID: 14751534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
    Chao KS; Bosch WR; Mutic S; Lewis JS; Dehdashti F; Mintun MA; Dempsey JF; Perez CA; Purdy JA; Welch MJ
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1171-82. PubMed ID: 11240261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy.
    Zhang L; Chen H; Wang L; Liu T; Yeh J; Lu G; Yang L; Mao H
    Nanotechnol Sci Appl; 2010 Dec; 3():159-70. PubMed ID: 24198480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry.
    Langmuir VK; Fowler JF; Knox SJ; Wessels BW; Sutherland RM; Wong JY
    Med Phys; 1993; 20(2 Pt 2):601-10. PubMed ID: 8492769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.